▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3558 by analyst upside · 2026-10-03
FRNM
Freenome, Inc.
Healthcare · Market Cap $2B · P/E 0x
ANALYST PRICE TARGET
+10.3%
implied upside to consensus target
Current Price $16.32
Consensus Target $18.0
Bull Target $21.0
Bear Target $17.0
Analysts Covering 5
ANALYST CONSENSUS - BUY
Strong Buy
0
Buy
5
Hold
0
Sell
0
52-Week Low $9.95
52-Week High $17.5
YTD Return +25.5%
FUNDAMENTALS
Market Cap $2B
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-2.07
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $35M
Profit Margin N/A
52-WEEK RANGE
52-Week Low $9.95
52-Week High $17.5
Current Price $16.32
Bear Target $17.0
Bull Target $21.0
● Now $16.32 ● Target $18.0
TRADING DATA
Avg Volume 779K
YTD Return +25.5%
Analyst Count 5
Consensus Buy
Upside to Target +10.3%
Last Updated 2026-10-03

ANALYST SUMMARY

Freenome, Inc. (FRNM) is currently trading at $16.32 with a Wall Street consensus price target of $18.0, implying potential upside of 10.3% over the next 12 months. 5 analysts currently cover FRNM, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $21.0, while the most cautious has a target of $17.0.

FRNM operates in the Healthcare sector with a market capitalisation of $2B. The stock is up 25.5% year-to-date and is currently trading near the upper end of its 52-week range of $9.95 – $17.5.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

LKFT +3.3%
Lakefront Biotherapeutics NV
$2B · P/E 2.9x · Underperform
AUPH +12.8%
Aurinia Pharmaceuticals Inc.
$2B · P/E 7.0x · Buy
NUTX +33.1%
Nutex Health Inc.
$1B · P/E 8.2x · Buy
MD +1.4%
Pediatrix Medical Group, Inc.
$2B · P/E 12.4x · Hold
PAHC +18.2%
Phibro Animal Health Corporation
$2B · P/E 15.3x · Hold

RECENT ANALYST CALLS

Upgrade/downgrade history for FRNM, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Guggenheim ● Initiated
Buy 2026-08-20 62% win rate (8 calls)
TD Cowen ● Initiated
Buy 2026-08-18 Building track record
Jefferies ● Initiated
Buy 2026-08-17 50% win rate (6 calls)
BTIG ● Initiated
Buy 2026-08-17 38% win rate (8 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
66
out of 100
Coverage depth
14/30
Consensus clarity
25/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →